Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

Author:

Hong Junshik1,Lee Yoo Jin2,Bae Sung Hwa3,Yi Jun Ho4,Park Sungwoo5,Chang Myung Hee6,Park Young Hoon7,Hyun Shin Young8,Chung Joo-Seop9,Jang Ji Eun10,Jung Joo Young11,Jeon So-Yeon12,Song Seo-Young13,Kim Hawk14,Kim Dae Sik15,Kim Sung-Hyun16,Kim Min Kyoung17,Han Sang Hoon18,Park Seonyang19,Kim Yoo-Jin20,Lee Je-Hwan21,

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea

2. Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

3. Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu Catholic University Hospital, Daegu, Korea

4. Division of Hematology-Oncology, Chung-Ang University Hospital, Seoul, Department of Internal Medicine, Jinju, Korea

5. Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea

6. National Health Insurance Service Ilsan Hospital, Goyang, Korea

7. Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea

8. Yonsei University Wonju College of Medicine, Wonju, Korea

9. Pusan National University College of Medicine, Pusan National University Hospital, Busan, Korea

10. Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

11. Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea

12. Division of Oncology and Hematology, Department of Internal Medicine, Jeonbuk National University Hospital-Jeonbuk National University Medical School, Jeonju, Korea

13. Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University Hospital, Chuncheon, Korea

14. Division of Hematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Division of Hematology-Oncology, Department of Internal Medicine, Seoul, Korea

15. Korea University Guro Hospital, Seoul, Korea

16. Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea

17. Yeungnam University College of Medicine, Daegu, Department of Internal Medicine, Jeju, Korea

18. Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea

19. Inje University Haeundae Paik Hospital, Busan, Korea

20. Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

21. University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Publisher

The Korean Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3